Logo image of TCBI

TEXAS CAPITAL BANCSHARES INC (TCBI) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:TCBI - US88224Q1076 - Common Stock

87.95 USD
+3.13 (+3.69%)
Last: 11/21/2025, 8:01:58 PM
87.95 USD
0 (0%)
After Hours: 11/21/2025, 8:01:58 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to TCBI. TCBI was compared to 387 industry peers in the Banks industry. TCBI has a bad profitability rating. Also its financial health evaluation is rather negative. TCBI is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

TCBI had positive earnings in the past year.
TCBI had a positive operating cash flow in the past year.
In the past 5 years TCBI has always been profitable.
Each year in the past 5 years TCBI had a positive operating cash flow.
TCBI Yearly Net Income VS EBIT VS OCF VS FCFTCBI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

1.2 Ratios

The Return On Assets of TCBI (0.87%) is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of 7.79%, TCBI is in line with its industry, outperforming 40.62% of the companies in the same industry.
Industry RankSector Rank
ROA 0.87%
ROE 7.79%
ROIC N/A
ROA(3y)0.64%
ROA(5y)0.55%
ROE(3y)5.83%
ROE(5y)5.35%
ROIC(3y)N/A
ROIC(5y)N/A
TCBI Yearly ROA, ROE, ROICTCBI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

TCBI's Profit Margin of 23.38% is in line compared to the rest of the industry. TCBI outperforms 45.24% of its industry peers.
In the last couple of years the Profit Margin of TCBI has declined.
The Operating Margin and Gross Margin are not available for TCBI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 23.38%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-37.07%
PM growth 5Y-25.53%
GM growth 3YN/A
GM growth 5YN/A
TCBI Yearly Profit, Operating, Gross MarginsTCBI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

3

2. Health

2.1 Basic Checks

TCBI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for TCBI has been reduced compared to 1 year ago.
The number of shares outstanding for TCBI has been reduced compared to 5 years ago.
The debt/assets ratio for TCBI has been reduced compared to a year ago.
TCBI Yearly Shares OutstandingTCBI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
TCBI Yearly Total Debt VS Total AssetsTCBI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

The Debt to FCF ratio of TCBI is 2.72, which is a good value as it means it would take TCBI, 2.72 years of fcf income to pay off all of its debts.
TCBI's Debt to FCF ratio of 2.72 is in line compared to the rest of the industry. TCBI outperforms 41.39% of its industry peers.
A Debt/Equity ratio of 0.17 indicates that TCBI is not too dependend on debt financing.
TCBI has a Debt to Equity ratio (0.17) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 2.72
Altman-Z N/A
ROIC/WACCN/A
WACC16.32%
TCBI Yearly LT Debt VS Equity VS FCFTCBI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
TCBI Yearly Current Assets VS Current LiabilitesTCBI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 90.34% over the past year.
Measured over the past years, TCBI shows a decrease in Earnings Per Share. The EPS has been decreasing by -7.07% on average per year.
Looking at the last year, TCBI shows a very strong growth in Revenue. The Revenue has grown by 35.49%.
TCBI shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.75% yearly.
EPS 1Y (TTM)90.34%
EPS 3Y-2.08%
EPS 5Y-7.07%
EPS Q2Q%34.57%
Revenue 1Y (TTM)35.49%
Revenue growth 3Y0.92%
Revenue growth 5Y-2.75%
Sales Q2Q%171.56%

3.2 Future

Based on estimates for the next years, TCBI will show a very strong growth in Earnings Per Share. The EPS will grow by 22.53% on average per year.
The Revenue is expected to grow by 12.49% on average over the next years. This is quite good.
EPS Next Y51.21%
EPS Next 2Y29.62%
EPS Next 3Y22.53%
EPS Next 5YN/A
Revenue Next Year22.96%
Revenue Next 2Y15.14%
Revenue Next 3Y12.49%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
TCBI Yearly Revenue VS EstimatesTCBI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B
TCBI Yearly EPS VS EstimatesTCBI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 14.39, TCBI is valued correctly.
Compared to the rest of the industry, the Price/Earnings ratio of TCBI indicates a slightly more expensive valuation: TCBI is more expensive than 67.35% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of TCBI to the average of the S&P500 Index (25.47), we can say TCBI is valued slightly cheaper.
A Price/Forward Earnings ratio of 12.15 indicates a correct valuation of TCBI.
Based on the Price/Forward Earnings ratio, TCBI is valued a bit more expensive than 67.35% of the companies in the same industry.
TCBI is valuated cheaply when we compare the Price/Forward Earnings ratio to 34.42, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 14.39
Fwd PE 12.15
TCBI Price Earnings VS Forward Price EarningsTCBI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

TCBI's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. TCBI is more expensive than 68.38% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.62
EV/EBITDA N/A
TCBI Per share dataTCBI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
TCBI's earnings are expected to grow with 22.53% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.28
PEG (5Y)N/A
EPS Next 2Y29.62%
EPS Next 3Y22.53%

0

5. Dividend

5.1 Amount

TCBI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

TEXAS CAPITAL BANCSHARES INC

NASDAQ:TCBI (11/21/2025, 8:01:58 PM)

After market: 87.95 0 (0%)

87.95

+3.13 (+3.69%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)10-22 2025-10-22/amc
Earnings (Next)01-21 2026-01-21/bmo
Inst Owners102.42%
Inst Owner Change0.32%
Ins Owners1.72%
Ins Owner Change0.37%
Market Cap4.01B
Revenue(TTM)1.21B
Net Income(TTM)283.36M
Analysts69
Price Target95.15 (8.19%)
Short Float %3.32%
Short Ratio3.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.37
Dividend Growth(5Y)13.5%
DP6.09%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.52%
Min EPS beat(2)20.5%
Max EPS beat(2)20.55%
EPS beat(4)3
Avg EPS beat(4)15.98%
Min EPS beat(4)-6.76%
Max EPS beat(4)29.63%
EPS beat(8)4
Avg EPS beat(8)5.27%
EPS beat(12)6
Avg EPS beat(12)0.95%
EPS beat(16)7
Avg EPS beat(16)-0.91%
Revenue beat(2)2
Avg Revenue beat(2)1.73%
Min Revenue beat(2)0.76%
Max Revenue beat(2)2.69%
Revenue beat(4)2
Avg Revenue beat(4)-0.45%
Min Revenue beat(4)-3.45%
Max Revenue beat(4)2.69%
Revenue beat(8)2
Avg Revenue beat(8)-7.6%
Revenue beat(12)4
Avg Revenue beat(12)2.04%
Revenue beat(16)7
Avg Revenue beat(16)1.48%
PT rev (1m)1.14%
PT rev (3m)1.21%
EPS NQ rev (1m)-4.17%
EPS NQ rev (3m)-3.57%
EPS NY rev (1m)4.04%
EPS NY rev (3m)14.26%
Revenue NQ rev (1m)-1.85%
Revenue NQ rev (3m)-2.09%
Revenue NY rev (1m)0.47%
Revenue NY rev (3m)0.39%
Valuation
Industry RankSector Rank
PE 14.39
Fwd PE 12.15
P/S 3.31
P/FCF 17.62
P/OCF 16.18
P/B 1.1
P/tB 1.1
EV/EBITDA N/A
EPS(TTM)6.11
EY6.95%
EPS(NY)7.24
Fwd EY8.23%
FCF(TTM)4.99
FCFY5.67%
OCF(TTM)5.44
OCFY6.18%
SpS26.56
BVpS79.69
TBVpS79.66
PEG (NY)0.28
PEG (5Y)N/A
Graham Number104.67
Profitability
Industry RankSector Rank
ROA 0.87%
ROE 7.79%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 23.38%
GM N/A
FCFM 18.79%
ROA(3y)0.64%
ROA(5y)0.55%
ROE(3y)5.83%
ROE(5y)5.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-37.07%
PM growth 5Y-25.53%
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 2.72
Debt/EBITDA N/A
Cap/Depr 39.37%
Cap/Sales 1.68%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 80.38%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score8
WACC16.32%
ROIC/WACCN/A
Cap/Depr(3y)61.66%
Cap/Depr(5y)38.62%
Cap/Sales(3y)3.13%
Cap/Sales(5y)2.02%
Profit Quality(3y)314.03%
Profit Quality(5y)1177.45%
High Growth Momentum
Growth
EPS 1Y (TTM)90.34%
EPS 3Y-2.08%
EPS 5Y-7.07%
EPS Q2Q%34.57%
EPS Next Y51.21%
EPS Next 2Y29.62%
EPS Next 3Y22.53%
EPS Next 5YN/A
Revenue 1Y (TTM)35.49%
Revenue growth 3Y0.92%
Revenue growth 5Y-2.75%
Sales Q2Q%171.56%
Revenue Next Year22.96%
Revenue Next 2Y15.14%
Revenue Next 3Y12.49%
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y113.65%
FCF growth 3Y-13.94%
FCF growth 5YN/A
OCF growth 1Y106.72%
OCF growth 3Y-9.88%
OCF growth 5YN/A

TEXAS CAPITAL BANCSHARES INC / TCBI FAQ

Can you provide the ChartMill fundamental rating for TEXAS CAPITAL BANCSHARES INC?

ChartMill assigns a fundamental rating of 4 / 10 to TCBI.


Can you provide the valuation status for TEXAS CAPITAL BANCSHARES INC?

ChartMill assigns a valuation rating of 4 / 10 to TEXAS CAPITAL BANCSHARES INC (TCBI). This can be considered as Fairly Valued.


How profitable is TEXAS CAPITAL BANCSHARES INC (TCBI) stock?

TEXAS CAPITAL BANCSHARES INC (TCBI) has a profitability rating of 3 / 10.


What are the PE and PB ratios of TEXAS CAPITAL BANCSHARES INC (TCBI) stock?

The Price/Earnings (PE) ratio for TEXAS CAPITAL BANCSHARES INC (TCBI) is 14.39 and the Price/Book (PB) ratio is 1.1.


What is the financial health of TEXAS CAPITAL BANCSHARES INC (TCBI) stock?

The financial health rating of TEXAS CAPITAL BANCSHARES INC (TCBI) is 3 / 10.